BACKGROUND: In TB outbreaks, detecting active cases is the key step in stopping transmission of the disease. The aim of this study was to evaluate the role of high-resolution CT (HRCT) scanning of the chest in the investigation of a TB outbreak that developed in a cohort of 92 soldiers in the South Korean army. METHODS: Outbreak investigation, including tuberculin skin test (TST), QuantiFERON TB Gold In-Tube (QFT) test, and simple chest radiograph (CXR), was performed. For participants with any abnormal findings in these tests, HRCT scanning was done. Active pulmonary TB was diagnosed based on sputum studies or HRCT scan findings. In addition, participants with positive results in both TST and QFT were treated as having a latent TB infection (LTBI). TST and QFT were repeated in participants with a positive result in one of these tests. CXR was repeated in all participants at 3 and 6 months of follow-up. RESULTS: Eighty-seven participants completed the study protocol. Among them, 18 active TB cases were diagnosed. Nine of these had normal CXR, but had lesions that were suggestive of active TB on HRCT scan. Twenty-two participants with normal HRCT scans and positive results with TST and QFT at initial investigation were treated as LTBI. Among 13 participants with normal CXR and positive results in either TST or QFT, nine completed a 3-month investigation. All but one of nine participants revealed positive results in both tests. CONCLUSION: Inclusion of HRCT scanning in the outbreak investigation of TB may be helpful in differentiating active TB from LTBI more reliably. TRIAL REGISTRATION: clinicaltrials.gov; Identifier: NCT00889759.
BACKGROUND: In TB outbreaks, detecting active cases is the key step in stopping transmission of the disease. The aim of this study was to evaluate the role of high-resolution CT (HRCT) scanning of the chest in the investigation of a TB outbreak that developed in a cohort of 92 soldiers in the South Korean army. METHODS: Outbreak investigation, including tuberculin skin test (TST), QuantiFERON TB Gold In-Tube (QFT) test, and simple chest radiograph (CXR), was performed. For participants with any abnormal findings in these tests, HRCT scanning was done. Active pulmonary TB was diagnosed based on sputum studies or HRCT scan findings. In addition, participants with positive results in both TST and QFT were treated as having a latent TB infection (LTBI). TST and QFT were repeated in participants with a positive result in one of these tests. CXR was repeated in all participants at 3 and 6 months of follow-up. RESULTS: Eighty-seven participants completed the study protocol. Among them, 18 active TB cases were diagnosed. Nine of these had normal CXR, but had lesions that were suggestive of active TB on HRCT scan. Twenty-two participants with normal HRCT scans and positive results with TST and QFT at initial investigation were treated as LTBI. Among 13 participants with normal CXR and positive results in either TST or QFT, nine completed a 3-month investigation. All but one of nine participants revealed positive results in both tests. CONCLUSION: Inclusion of HRCT scanning in the outbreak investigation of TB may be helpful in differentiating active TB from LTBI more reliably. TRIAL REGISTRATION: clinicaltrials.gov; Identifier: NCT00889759.
Authors: Julius Matthias Weinrich; Roland Diel; Markus Sauer; Frank Oliver Henes; Karen Meywald-Walter; Gerhard Adam; Gerhard Schön; Peter Bannas Journal: Eur Radiol Date: 2017-01-03 Impact factor: 5.315
Authors: Young Ae Kang; Bonhan Koo; Yong Shin; Sei Won Lee; Ock-Hwa Kim; Joung Ha Park; Ho Cheol Kim; Hyo Joo Lee; Myoung Gyu Kim; Youngwon Jang; Na Hyun Kim; Yong Seo Koo; Sung-Han Kim Journal: Microbiol Spectr Date: 2022-05-19
Authors: Shinya Watanabe; Michael Zimmermann; Michael B Goodwin; Uwe Sauer; Clifton E Barry; Helena I Boshoff Journal: PLoS Pathog Date: 2011-10-06 Impact factor: 6.823
Authors: Gordon Wells; Joel N Glasgow; Kievershen Nargan; Kapongo Lumamba; Rajhmun Madansein; Kameel Maharaj; Robert L Hunter; Threnesan Naidoo; Llelani Coetzer; Stephan le Roux; Anton du Plessis; Adrie J C Steyn Journal: Am J Respir Crit Care Med Date: 2021-09-01 Impact factor: 30.528